SurvivorNet on MSN

New approval means more bladder cancer patients can access powerful immunotherapy combination: What to know about Keytruda + Padcev

A new treatment combination - Keytruda plus Padcev - is now approved for use before and after bladder‑removal surgery, ...
The Manila Times

CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology

Data reinforce durable responses, bladder preservation, low rate of disease progression, and favorable safety and tolerability in patients with high-risk, BCG-unresponsive non-muscle invasive bladder ...

New treatment approach improves survival, reduces recurrence risk in muscle-invasive bladder cancer

Researchers have found that a combination of enfortumab vedotin and pembrolizumab helps patients with muscle-invasive bladder ...
New York Post

J&J’s bladder cancer treatment approved by FDA — paving way for potential surgery-free option

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...
CNN

New ways to treat bladder cancer improve survival and shake up the standard of care, new studies show

A new combination of cancer medications appears to extend overall survival in patients with advanced bladder cancer more than the chemotherapies currently used as the standard of care. The research, ...

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV® ...
Cure Today

Reflections After Nine Years as a Bladder Cancer Survivor

Bladder cancer was diagnosed through cystoscopy, with initial treatment involving surgery and Bacillus Calmette-Guérin immunotherapy. Recurrence required further surgery. Shared exposure to ...
Medical Xpress

Bladder cancer: What you should know about diagnosis, treatment and recurrence

Bladder cancer is one of the most common cancer types in the U.S., according to the National Cancer Institute. It's also one of the most likely types of cancer to recur. Experts are developing ways to ...

European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First PD-1 Inhibitor Plus Antibody-Drug Conjugate Regimen for Adults With ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with Padcev® (enfortumab vedotin-ejfv ...
Medical News Today

What to know about diet for bladder cancer

No single food can protect against or treat bladder cancer. However, studies indicate a nutritious, balanced diet helps reduce the risk of many cancers. There is no guaranteed way to prevent bladder ...
The Denver Post

Deion Sanders had bladder cancer. Here’s what to know about a disease that’s more common in men

Getting your Trinity Audio player ready... By DEVI SHASTRI Colorado football coach Deion Sanders was diagnosed with an aggressive form of bladder cancer earlier this year, had surgery to remove the ...